Refine by
Carcinoma Squamous Equipment & Supplies
76 equipment items found
Manufactured by:Creative BioMart based in, NEW YORK (USA)
Keratin 8 belongs to the type B (basic) subfamily of high molecular weight keratins and exists in combination with keratin 18. Keratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular ...
by:Alfa Cytology based inU.S. VIRGIN ISLANDS
KP372-1 is also an NQO1 redox cycling agent that causes DNA damage (including DNA breakage) by generating ROS. KP372-1 can be used in cancer research (such as head and neck squamous cell carcinoma (HNSCC) and pancreatic cancer). ...
Manufactured by:Medinfar Group based inAmadora, PORTUGAL
Actinic Keratosis is a very common skin disease characterized by superficial lesions, which appear on skin that has been exposed to the sun. (1);(2). Actinic Keratosis are deemed pre-cancerous lesions because they can evolve into squamous cell carcinoma. As such, ALL ACTINIC KERATOSIS MUST BE TREATED. Actinic Keratosis usually appear as one or more brownish red ...
Manufactured by:EDM3 Solutions based inJacksonville, FLORIDA (USA)
Tissue staining is the cornerstone of Mohs Micrographic Surgery (MMS). EDM3s new “all inclusive” Mohs Lab Staining Kit, will consistently yield slides with the highest quality, excellent morphology and differentiation of target cellular components. The kit includes marking dyes, freezing medium, bleaching reagents, both Hematoxylin and Eosin (H&E) and Toluidine Blue (T-blue) ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
Bladder cancer is one of the most common types of cancer which like lung and other cancers, is quite heterogeneous. Bladder cancer occurs more frequently in men than women, generally at an older age, and is more common among smokers than non-smokers. The most common type of bladder cancer begins within cells that line the inside of the bladder, urothelial cells – also called transitional ...
Manufactured by:Episkin based inLyon Cedex 7, FRANCE
The SkinEthicTM HOE model is composed of TR146 cells (derived from a squamous cell carcinoma of the buccal mucosa) cultivated on an inert polycarbonate filter at the air liquid interface in a chemically defined medium. This model forms an epithelial tissue devoid of stratum corneum, resembling histologically to the mucosa of the oral ...
Manufactured by:Fujirebio based inMalvern, PENNSYLVANIA (USA)
CanChek Tumor Marker Control Serum is intended for use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma antigen (SCCA). The use of a quality control serum is indicated to verify the performance characteristics of an in vitro diagnostic laboratory test and ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
Nano-mAbs is the invention of Dr Hong Hoi Ting, an internationally regarded radiopharmaceutical and nuclear medicine expert, formerly from the University of ...
Manufactured by:Holostem Terapie Avanzate S.r.l. based inModena, ITALY
Epidermolysis Bullosa (EB) is a group of genetic adhesion disorders characterized by fragility of the skin. EB are devastating, highly disfiguring, blistering pathologies that severely impairs the quality of life of patients and affect approximately 500,000 people worldwide ...
by:Traws Pharma based inNewtown, PENNSYLVANIA (USA)
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but acts via allosteric inhibition. Rigosertib has the potential to affect three critical pathways for cancer cell proliferation and survival: the ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
Manufactured by:GeneCentric Therapeutics, Inc. based inDurham, NORTH CAROLINA (USA)
Head and Neck Cancer, a group of cancers that starts within the mouth, nose, throat, larynx, sinuses, or salivary glands, is the seventh most common of all cancers. Because most majority begin in squamous cells which line the moist surfaces inside the head and neck areas, such cancers are also referred to as Head and Neck Squamous Cell Carcinomas ...
Manufactured by:MEDlight GmbH based inHERFORD, GERMANY
Painfree Compact Daylight PDT; Enhanced conventional PDT; Large adjustable treament area; New touchscreen with many features; Highly flexible and adjustable device arm; Premium design with durable high quality ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
Manufactured by:AVITA Medical based inValencia, CALIFORNIA (USA)
Epidermolysis Bullosa (EB) is a group of rare and incurable skin disorders caused by mutations in genes encoding structural proteins resulting in skin fragility and blistering, leading to chronic wounds and, in some sub-types, an increased risk of squamous cell carcinoma or death. Dystrophic EB is estimated to affect 3-8 million people[1], and there is currently ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
Henlius actively promotes HANSIZHUANG in conjunction with in-house products of the company and innovative therapies, and has initiated many clinical trials on immuno-oncology combination therapies of HANSIZHUANG worldwide, covering a wide range of indications, such as lung cancer, esophageal carcinoma, head and neck squamous cell carcinoma and ...
Manufactured by:Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc. based inRockville, MARYLAND (USA)
Building on the clinical advancement of VCN-01, Theriva developed the Albumin Shield™ technology to protect oncolytic viruses from circulating anti-oncolytic virus antibodies after systemic administration. We anticipate that this technology will enable multiple oncolytic virus doses to be administered in therapeutic cycles to treat particularly refractory ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling more informed choices about treatment and follow-up ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
AVβ6 is the invention of internationally regarded integrin expert Professor Johannes Notni, formerly at the Technical University of Munich and now Professor at Essen University. ...
Manufactured by:TC BioPharm based inHolytown, UNITED KINGDOM
Previous efforts to target B7-H4 expression have been limited by off-tumor toxicity which makes it an ideal candidate for GDTs with a Co-stim CAR. Additionally, B7-H4 is a potential cancer stem cell marker in esophageal squamous cell carcinoma – this may permit targeting of the tumor initiating compartment. ...